Pharmaceuticals.jpg

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

16915-70-1

Nifursol

16915-70-1
42200-33-9

Nadolol

42200-33-9
57226-68-3

Norfluoxetine HCl

57226-68-3
129618-40-2

Nevirapin

129618-40-2
67-20-9

Nitrofurantoin

67-20-9
28643-80-3

Nigericin sodium

28643-80-3
1400-61-9

Nystatin

1400-61-9
58652-20-3

Nomegestrol acetate

58652-20-3
50-65-7

Niclosamide

50-65-7
104206-65-7

Nitisinone

104206-65-7
147676-99-1

Nitrodenafil

147676-99-1
434-22-0

19-Nortestosterone

434-22-0
51-41-2

(-)-Norepinephrine

51-41-2
126924-38-7

(S)-Norfluoxetine

126924-38-7
7681-93-8

Natamycin

7681-93-8
494-98-4

Beta-Nornicotyrine

494-98-4
62-90-8

Nandrolone Phenpropionate

62-90-8
3000-81-5

N-Formylnornicotine

3000-81-5
23277-43-2

Nalbuphine HCl H2O

23277-43-2
51095-86-4

(1'S,2'S)-Nicotine 1'-Oxide

51095-86-4